Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Kosugi

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Blood|November 26, 2011
Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPHLi Yin, Michio Kosugi, Donald Kufe
International Journal of Clinical Oncology|December 12, 2007
Brachytherapy with permanent seed implantationShiro Saito, Hirohiko Nagata, Michio Kosugi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 11, 2003
[Neuroendocrine differentiation in adenocarcinoma of the prostate with progression of disease during hormonal treatment: a report of two cases]Michio Kosugi, Yasumasa Hanawa, Tetsuo Momma, et al.
Plos One|December 6, 2011
MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cellsMichio Kosugi, Rehan Ahmad, Maroof Alam, et al.
Human Cell|May 18, 2007
Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Urology|January 27, 2009
Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Asian Journal of Endoscopic Surgery|June 29, 2024
Robot-assisted radical cystectomy for bladder cancer after low anterior resection: A case reportShoutarou Watanabe, Hiroaki Kobayashi, Nao Hiroe, et al.
Japanese Journal of Clinical Oncology|January 27, 2007
Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetryToshio Ohashi, Atsunori Yorozu, Kazuhito Toya, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 31, 2017
PREDICTIVE FACTORS OF THE INITIAL TREATMENT FOR 207 BLUNT RENAL TRAUMA CASES BASED ON THE CLASSIFICATION FOR RENAL INJURY OF JAPANESE ASSOCIATION FOR THE SURGERY OF TRAUMA 2008's VERSIONKimiharu Takamatsu, Yosuke Nakajima, Masaru Ishida, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Blood|November 26, 2011
Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPHLi Yin, Michio Kosugi, Donald Kufe
International Journal of Clinical Oncology|December 12, 2007
Brachytherapy with permanent seed implantationShiro Saito, Hirohiko Nagata, Michio Kosugi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 11, 2003
[Neuroendocrine differentiation in adenocarcinoma of the prostate with progression of disease during hormonal treatment: a report of two cases]Michio Kosugi, Yasumasa Hanawa, Tetsuo Momma, et al.
Plos One|December 6, 2011
MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cellsMichio Kosugi, Rehan Ahmad, Maroof Alam, et al.
Human Cell|May 18, 2007
Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Urology|January 27, 2009
Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Asian Journal of Endoscopic Surgery|June 29, 2024
Robot-assisted radical cystectomy for bladder cancer after low anterior resection: A case reportShoutarou Watanabe, Hiroaki Kobayashi, Nao Hiroe, et al.
Japanese Journal of Clinical Oncology|January 27, 2007
Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetryToshio Ohashi, Atsunori Yorozu, Kazuhito Toya, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 31, 2017
PREDICTIVE FACTORS OF THE INITIAL TREATMENT FOR 207 BLUNT RENAL TRAUMA CASES BASED ON THE CLASSIFICATION FOR RENAL INJURY OF JAPANESE ASSOCIATION FOR THE SURGERY OF TRAUMA 2008's VERSIONKimiharu Takamatsu, Yosuke Nakajima, Masaru Ishida, et al.
Pageof 3